You are about to leave jnjmedtech.com. By clicking to continue, you will be taken to a web site governed by their own Legal and Privacy Policies.
Ethicon
Wound Closure
Ethicon
Wound Closure
Johnson & Johnson started mass production of sterile sutures in 1887, and today Ethicon continues to pioneer advances in wound closure.
MEDIA
Johnson & Johnson started mass production of sterile sutures in 1887, and today Ethicon continues to pioneer advances in wound closure.
STRATAFIX™
With significantly more points of fixation than traditional sutures, STRATAFIX™ Knotless Tissue Control Devices allowed for more consistent tension control over every pass and combined the strengthiii and securityiv of interrupted closure with the speedv of continuous closure.3-7,vi
Plus Antibacterial Sutures
Plus Sutures were associated with a nearly 30%vii reduction in the risk of surgical site infection.8
Plus Antibacterial Sutures have been shown in vitro to inhibit bacterial colonization of the suture for 7 days or more and are effective against the most common organisms associated with SSIsviii: 9-11
- Staphylococcus aureus
- Staphylococcus epidermidis
- MRSA
- MRSE
- Escherichia colivi
- K pneumoniaevi
DERMABOND™ PRINEO™
DERMABOND™ PRINEO™ Skin Closure System provided a flexible microbial barrier with 98.43% protection in vitro for 72 hours against organisms commonly responsible for SSIs.12,ix,x
DERMABOND™ PRINEO™ led to greater overall patient satisfaction compared to skin staples. 13-15,xi
Traditional wound closure techniques involving conventional suture, staples and wound dressings may not be the optimal choice to achieve the primary objective of multi-layer, watertight closure.2
Reducing risk factors and improving healing can be achieved with appropriate surgical technique and postoperative care. You can optimise tissue management through the principles of wound healing: gentle handling of tissues, careful haemostasis, obliteration of dead space,and avoidance of tension.16,17 Appropriate choice of wound dressing should manage wound bioburden, limit cross contamination and promote a wound healing environment. 18
STRATAFIX™ increased wound-holding security without knots. 6,7,19,vi,xii,xiii
STRATAFIX™ provided better watertight closure. 19,vi,xiv,xv
STRATAFIX™: the only antibacterial barbed suture.20-23,vi,xvi,xvii
STRATAFIX™: the only barbed suture appropriate for fascia.3,24,vi,xviii,xix
STRATAFIX™: faster xx, stronger xix, more secure xxi.3,6,7,25,26
STRATAFIX™ Symmetric demonstrated superior tissue holding strength.3,xxii
Let’s work together to reduce infection risk, shorten length of stay and minimise readmissions.
DERMABOND™ PRINEO™ Skin Closure System vs. traditional sutures and staples respectively, were associated with:
Close faster with DERMABOND™ PRINEO™.27,xxiii,xxiv
DERMABOND™ PRINEO™: 98.43% protection. 12,x,xxv
DERMABOND™ PRINEO™ reduced readmission rates. 28,29, xxvi, xxvii
DERMABOND™ PRINEO™ allows for visibility of the wound.30,31, xxviii, xxix
DERMABOND™ PRINEO™: less post-op care.13,xi
DERMABOND™ PRINEO™ increased patient satisfaction.13-15,xi
All Wound Closure Products
Helpful Links
Hip Arthroplasty
Knee Arthroplasty
Care4today
Ethicon Home
Ethicon Customer Support
© Johnson & Johnson Medical NV., 2023.
This site is published by Johnson & Johnson Medical N.V., which is solely responsible for its contents and is intended for EMEA audiences only. This site is intended for Healthcare Professionals. If you are a patient, it is important that you discuss information about the benefits and risks of products with your doctor.
The third-party trademarks used herein are trademarks of their respective owners. Data and usage fees may apply. See your carrier for more information.
*As of March 2017, per internal research conducted by Ethicon.
Please refer always to the Instructions for Use / Package Insert that come with the device for the most current and complete instructions.